<?xml version="1.0" encoding="UTF-8"?>
<p>OGDH is vital for Krebs cycle metabolism and is a source of ROS (Mailloux et al. 
 <xref rid="CIT0024" ref-type="bibr">2016a</xref>). RosA reduced 
 <italic>ogdh</italic> mRNA (164.8 ± 36.8% vs. 287.7 ± 32.0%, 
 <xref ref-type="fig" rid="F0008">Figure 8(A)</xref>) and protein (216.5 ± 18.4% vs. 286.4 ± 18.0%, 
 <xref ref-type="fig" rid="F0008">Figure 8(B,C)</xref>) levels in the area of myocardial I/R injury. RosA also reduced 
 <italic>ogdh</italic> mRNA (158.7 ± 18.6% vs. 228.7 ± 31.7%, 
 <xref ref-type="fig" rid="F0008">Figure 8(D</xref>) and protein (204.7 ± 19.9% vs. 314.8 ± 18.5%, 
 <xref ref-type="fig" rid="F0008">Figure 8(E,F)</xref>) levels after OGD/R injury in cells.
</p>
